SummaryRMgm-4946
|
Successful modification | The parasite was generated by the genetic modification |
The mutant contains the following genetic modification(s) | Introduction of a transgene |
Reference (PubMed-PMID number) |
Reference 1 (PMID number) : 33307135 |
MR4 number | |
top of page | |
Parent parasite used to introduce the genetic modification | |
Rodent Malaria Parasite | P. yoelii |
Parent strain/line | P. y. yoelii 17XNL |
Name parent line/clone | Not applicable |
Other information parent line | |
top of page | |
The mutant parasite was generated by | |
Name PI/Researcher | Liu C, Yuan J |
Name Group/Department | State Key Laboratory of Cellular Stress Biology, Innovation Center for Cell Signal Network, School o |
Name Institute | Xiamen University |
City | Xiamen, Fujian |
Country | China |
top of page | |
Name of the mutant parasite | |
RMgm number | RMgm-4946 |
Principal name | soap-Tir1-Tir1 |
Alternative name | |
Standardized name | |
Is the mutant parasite cloned after genetic modification | No |
top of page | |
Phenotype | |
Asexual blood stage | Not different from wild type |
Gametocyte/Gamete | Not different from wild type |
Fertilization and ookinete | Tir1::Flag fusion protein is highly expressed in ookinetes |
Oocyst | Not tested |
Sporozoite | Not tested |
Liver stage | Not tested |
Additional remarks phenotype | Mutant/mutation Phenotype We noticed that in the ookinetes of eef1a-Tir1/cdc50c::aid parasites, we failed to detect a clear depletion of 50C-AID even after 3 hours of auxin treatment, which is likely due to the relatively lower Tir1 expression in the ookinetes compared to that in the asexual blood stage and gametocytes. Therefore, we attempted to engineer a transgenic line to achieve higher Tir1 expression in the ookinetes. To that end, we used the promoter of soap (PY17X_1040200), a gene specifically and highly expressed in the ookinetes and early oocysts, to drive the Tir1 expression. Using the CRISPR/Cas9 method, we replaced the eef1a promoter with the soap promoter (1999bp) at the upstream of Tir1 in the eef1a-Tir1 parasites (RMgm-4945), and generated a new line designated as soap-Tir1 (RMgm-4946). As expected, the Tir1 protein is highly expressed in the ookinetes, but not in the asexual blood stage of the soap-Tir1 parasites |
top of page | |||||||||||||||||||
Type and details of transgene | |||||||||||||||||||
Is the transgene Plasmodium derived | Transgene: not Plasmodium | ||||||||||||||||||
Transgene name | the plant Oryza sativa auxin receptor transport inhibitor response 1 (TIR1) | ||||||||||||||||||
top of page | |||||||||||||||||||
Details of the genetic modification | |||||||||||||||||||
Inducable system used | No | ||||||||||||||||||
Additional remarks inducable system | |||||||||||||||||||
Type of plasmid/construct | CRISPR/Cas9 construct: integration through double strand break repair | ||||||||||||||||||
PlasmoGEM (Sanger) construct/vector used | No | ||||||||||||||||||
Modified PlasmoGEM construct/vector used | No | ||||||||||||||||||
Plasmid/construct map | |||||||||||||||||||
Plasmid/construct sequence | |||||||||||||||||||
Restriction sites to linearize plasmid | |||||||||||||||||||
Selectable marker used to select the mutant parasite | hdhfr/yfcu | ||||||||||||||||||
Promoter of the selectable marker | eef1a | ||||||||||||||||||
Selection (positive) procedure | pyrimethamine | ||||||||||||||||||
Selection (negative) procedure | 5-fluorocytosine (5-FC) | ||||||||||||||||||
Additional remarks genetic modification | The CRISPR/Cas9 plasmid pYCm was used to edit the parasite genome. To generate the plasmid for deleting the gene p230p (PY17X_0306600), a 973 bp of the 5’ untranslational region (UTR) upstream the initiation codon and an 857 bp of the 3’UTR following the translation stop codon were amplified as the homologous left and right arm, respectively. The left and right arms were inserted into the pYCm plasmid. Eight single guide RNAs (sgRNAs) were designed to target the coding region of the p230p gene. To generate the plasmid for replacing the coding region of p230p gene with the Tir1 expression cassette, the coding sequence of Tir1 was amplified from the Oryza sativa genome, tagged with a Flag epitope sequence, and put under the control of both the 5’UTR (promoter) of eef1a (551 bp) and the 3’UTR of the dhfr (456 bp). The Tir1 expression cassette was inserted between the left and right homologous arms in the pYCm plasmid. We noticed that in the ookinetes of eef1a-Tir1/cdc50c::aid parasites, we failed to detect a clear depletion of 50C-AID even after 3 hours of auxin treatment, which is likely due to the relatively lower Tir1 expression in the ookinetes compared to that in the asexual blood stage and gametocytes. Therefore, we attempted to engineer a transgenic line to achieve higher Tir1 expression in the ookinetes. To that end, we used the promoter of soap (PY17X_1040200), a gene specifically and highly expressed in the ookinetes and early oocysts, to drive the Tir1 expression. Using the CRISPR/Cas9 method, we replaced the eef1a promoter with the soap promoter (1999bp) at the upstream of Tir1 in the eef1a-Tir1 parasites (RMgm-4945), and generated a new line designated as soap-Tir1 (RMgm-4946). As expected, the Tir1 protein is highly expressed in the ookinetes, but not in the asexual blood stage of the soap-Tir1 parasites | ||||||||||||||||||
Additional remarks selection procedure | Purified parasites were electroporated with 5 ug circular plasmid DNA, immediately injected i.v. into a naïve mouse, and subjected to selection with pyr provided in drinking water at a concentration of 6 mg/L from day 2 after electroporation. Pyr resistant parasites usually appear 5–6 days after drug selection. Parasite genomic DNAs from infected mouse blood were isolated and used for PCR genotyping. Correct 5’ and 3’ integrations were confirmed by PCR To remove the plasmids within the transfected parasites after prior pyr drug selection, parasites were subjected to negative selection with 5-fluorocytosine (5-FC, Sigma Aldrich, F6627). 5-FC was prepared in water at a final concentration of 2.0 mg/ml and was provided to the animals in a dark drinking bottle. A naïve mouse receiving parasites containing residual plasmids after Pyr selection was subjected to 5-FC pressure for 8 days, with a change of new drug at day 4. Complete removal of plasmids in parasites was confirmed by PCR genotyping | ||||||||||||||||||
top of page | |||||||||||||||||||
Other details transgene | |||||||||||||||||||
top of page | |||||||||||||||||||
Promoter | |||||||||||||||||||
Gene Model of Parasite | PY17X_1040200 | ||||||||||||||||||
Gene Model P. falciparum ortholog | PF3D7_1404300 | ||||||||||||||||||
Gene product | secreted ookinete adhesive protein, putative | ||||||||||||||||||
Gene product: Alternative name | soap | ||||||||||||||||||
| |||||||||||||||||||
top of page | |||||||||||||||||||
3'-UTR | |||||||||||||||||||
Gene Model of Parasite | PY17X_0719300 | ||||||||||||||||||
Gene product | bifunctional dihydrofolate reductase-thymidylate synthase, putative | ||||||||||||||||||
Gene product: Alternative name | DHFR-TS | ||||||||||||||||||
| |||||||||||||||||||
Insertion/Replacement locus | |||||||||||||||||||
Replacement / Insertion | Insertion locus | ||||||||||||||||||
Gene Model of Parasite | PY17X_0306600 | ||||||||||||||||||
Gene product | 6-cysteine protein P230p | ||||||||||||||||||
Gene product: Alternative name | |||||||||||||||||||
| |||||||||||||||||||
top of page |